These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 30377997)

  • 41. Prognostic Significance of Cardiac
    Seo M; Yamada T; Tamaki S; Watanabe T; Morita T; Furukawa Y; Kawasaki M; Kikuchi A; Kawai T; Nakamura J; Kayama K; Kawahira M; Kimura T; Ueda K; Sakamoto D; Sakata Y; Fukunami M
    JACC Cardiovasc Imaging; 2022 Apr; 15(4):655-668. PubMed ID: 34656490
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cardiac iodine-123 metaiodobenzylguanidine (123I-MIBG) scintigraphy parameter predicts cardiac and cerebrovascular events in type 2 diabetic patients without structural heart disease.
    Yufu K; Takahashi N; Okada N; Shinohara T; Nakagawa M; Hara M; Yoshimatsu H; Saikawa T
    Circ J; 2012; 76(2):399-404. PubMed ID: 22130318
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Usefulness of meta-[123I]iodobenzylguanidine myocardial scintigraphy for predicting cardiac events in patients with dilated cardiomyopathy who receive long-term beta blocker treatment.
    Fujimoto S; Inoue A; Hisatake S; Yamashina S; Yamashina H; Nakano H; Yamazaki J
    Nucl Med Commun; 2005 Feb; 26(2):97-102. PubMed ID: 15657500
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prognostic values of
    Hashimoto H; Nakanishi R; Mizumura S; Hashimoto Y; Okamura Y; Yamanaka K; Yamazaki J; Ikeda T
    J Nucl Cardiol; 2020 Jun; 27(3):833-842. PubMed ID: 30386980
    [TBL] [Abstract][Full Text] [Related]  

  • 45. ACE inhibition reduces cardiac iodine-123-MIBG release in heart failure.
    Takeishi Y; Atsumi H; Fujiwara S; Takahashi K; Tomoike H
    J Nucl Med; 1997 Jul; 38(7):1085-9. PubMed ID: 9225795
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Renal dysfunction does not affect the prognostic value of myocardial iodine-123 meta-iodobenzylguanidine imaging in heart failure.
    Malhotra S; Wang L; Bunker CH; Winger D; Soman P
    Nucl Med Commun; 2014 Jan; 35(1):58-63. PubMed ID: 24177039
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prognostic value of iodine-123-metaiodobenzylguanidine myocardial uptake and heart rate variability in chronic congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.
    Anastasiou-Nana MI; Terrovitis JV; Athanasoulis T; Karaloizos L; Geramoutsos A; Pappa L; Tsagalou EP; Efentakis S; Nanas JN
    Am J Cardiol; 2005 Aug; 96(3):427-31. PubMed ID: 16054475
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cardiac 123I-MIBG Imaging for Clinical Decision Making: 22-Year Experience in Japan.
    Nakajima K; Nakata T
    J Nucl Med; 2015 Jun; 56 Suppl 4():11S-19S. PubMed ID: 26033897
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prognostic significance of cardiac I-123-metaiodobenzylguanidine imaging in patients with reduced, mid-range, and preserved left ventricular ejection fraction admitted for acute decompensated heart failure: a prospective study in Osaka Prefectural Acute Heart Failure Registry (OPAR).
    Seo M; Yamada T; Tamaki S; Watanabe T; Morita T; Furukawa Y; Kawasaki M; Kikuchi A; Kawai T; Abe M; Nakamura J; Yamamoto K; Kayama K; Kawahira M; Tanabe K; Kimura T; Ueda K; Sakamoto D; Sakata Y; Fukunami M
    Eur Heart J Cardiovasc Imaging; 2021 Jan; 22(1):58-66. PubMed ID: 32091079
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Assessment of cardiac sympathetic activity by MIBG imaging in patients with heart failure: a clinical appraisal.
    Perrone-Filardi P; Paolillo S; Dellegrottaglie S; Gargiulo P; Savarese G; Marciano C; Casaretti L; Cecere M; Musella F; Pirozzi E; Parente A; Cuocolo A
    Heart; 2011 Nov; 97(22):1828-33. PubMed ID: 21917663
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Validation of 2-year 123I-meta-iodobenzylguanidine-based cardiac mortality risk model in chronic heart failure.
    Nakajima K; Nakata T; Doi T; Kadokami T; Matsuo S; Konno T; Yamada T; Jacobson AF
    Eur Heart J Cardiovasc Imaging; 2018 Jul; 19(7):749-756. PubMed ID: 29415138
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Quality and utility of [
    Teresińska A; Woźniak O; Maciąg A; Wnuk J; Jezierski J; Fronczak A; Biernacka EK
    Ann Nucl Med; 2021 Aug; 35(8):916-926. PubMed ID: 34023989
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Long-term effects of the angiotensin-converting enzyme inhibitor enalapril on chronic heart failure. Examination by 123I-MIBG imaging.
    Soeki T; Tamura Y; Bandou K; Tanaka H; Takeichi N; Shinohara H; Yui Y; Fukuda N; Sui O
    Jpn Heart J; 1998 Nov; 39(6):743-51. PubMed ID: 10089936
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Assessment of most appropriate background subtraction method for quantification of 123I-metaiodobenzylguanidine (MIBG) myocardial uptake by comparing with plasma ANP and BNP].
    Yahara Y; Nomura Y; Okamoto S; Saitou K; Okamoto R; Makino K; Aoki S; Takeda K
    Kaku Igaku; 2000 May; 37(3):217-25. PubMed ID: 10860352
    [TBL] [Abstract][Full Text] [Related]  

  • 55. 123I-mIBG scintigraphy to predict risk for adverse cardiac outcomes in heart failure patients: design of two prospective multicenter international trials.
    Jacobson AF; Lombard J; Banerjee G; Camici PG
    J Nucl Cardiol; 2009; 16(1):113-21. PubMed ID: 19152136
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Relationship between late ventricular potentials and myocardial 123I-metaiodobenzylguanidine scintigraphy in patients with dilated cardiomyopathy with mild to moderate heart failure: results of a prospective study of sudden death events.
    Kasama S; Toyama T; Kaneko Y; Iwasaki T; Sumino H; Kumakura H; Minami K; Ichikawa S; Matsumoto N; Sato Y; Kurabayashi M
    Eur J Nucl Med Mol Imaging; 2012 Jun; 39(6):1056-64. PubMed ID: 22415599
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Selective improvement in Seattle Heart Failure Model risk stratification using iodine-123 meta-iodobenzylguanidine imaging.
    Ketchum ES; Jacobson AF; Caldwell JH; Senior R; Cerqueira MD; Thomas GS; Agostini D; Narula J; Levy WC
    J Nucl Cardiol; 2012 Oct; 19(5):1007-16. PubMed ID: 22949270
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Polymorphism of SLC6A2 gene does not influence outcome of myocardial
    Verschure DO; Baas F; van Eck-Smit BLF; Somsen GA; Verberne HJ
    J Nucl Cardiol; 2018 Jun; 25(3):900-906. PubMed ID: 27844334
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Persistence of
    Piña IL; Carson P; Lindenfeld J; Archambault WT; Jacobson AF
    Am J Cardiol; 2017 Feb; 119(3):434-439. PubMed ID: 27912890
    [No Abstract]   [Full Text] [Related]  

  • 60. Simultaneous assessment of regional adrenergic activity and perfusion with 123I-MIBG and 201Tl in congestive heart failure.
    Seto H; Shimizu M; Nozawa T; Yoshida N; Inagaki S; Kageyama M; Kakishita M
    Nucl Med Commun; 1996 Mar; 17(3):225-30. PubMed ID: 8692490
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.